EE200200703A - Beeta-blokaatorit ja vajadusel kolesterooli alandavat ainet sisaldav uus ravimvorm - Google Patents

Beeta-blokaatorit ja vajadusel kolesterooli alandavat ainet sisaldav uus ravimvorm

Info

Publication number
EE200200703A
EE200200703A EEP200200703A EEP200200703A EE200200703A EE 200200703 A EE200200703 A EE 200200703A EE P200200703 A EEP200200703 A EE P200200703A EE P200200703 A EEP200200703 A EE P200200703A EE 200200703 A EE200200703 A EE 200200703A
Authority
EE
Estonia
Prior art keywords
blocker
cholesterol
beta
necessary
formulation containing
Prior art date
Application number
EEP200200703A
Other languages
English (en)
Estonian (et)
Inventor
Berglund G�ran
Wikstrand John
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of EE200200703A publication Critical patent/EE200200703A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/366—Lactones having six-membered rings, e.g. delta-lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/06—Antibacterial agents for tuberculosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Emergency Medicine (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Toxicology (AREA)
  • Communicable Diseases (AREA)
  • Pulmonology (AREA)
  • Psychiatry (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Indole Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Pyrane Compounds (AREA)
EEP200200703A 2000-06-22 2001-06-15 Beeta-blokaatorit ja vajadusel kolesterooli alandavat ainet sisaldav uus ravimvorm EE200200703A (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE0002354A SE0002354D0 (sv) 2000-06-22 2000-06-22 New formulation
PCT/SE2001/001380 WO2001097751A2 (en) 2000-06-22 2001-06-15 New formulation comprising a betablocker and optionally a cholesterol-lowering agent

Publications (1)

Publication Number Publication Date
EE200200703A true EE200200703A (et) 2004-08-16

Family

ID=20280209

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200200703A EE200200703A (et) 2000-06-22 2001-06-15 Beeta-blokaatorit ja vajadusel kolesterooli alandavat ainet sisaldav uus ravimvorm

Country Status (28)

Country Link
US (2) US20030191177A1 (de)
EP (1) EP1296716B1 (de)
JP (1) JP2003535875A (de)
KR (1) KR20030010750A (de)
CN (1) CN1437484A (de)
AR (1) AR028699A1 (de)
AT (1) ATE344675T1 (de)
AU (1) AU2001274766A1 (de)
BG (1) BG107373A (de)
BR (1) BR0111790A (de)
CA (1) CA2411100A1 (de)
CZ (1) CZ20024181A3 (de)
DE (1) DE60124400T2 (de)
EE (1) EE200200703A (de)
ES (1) ES2274892T3 (de)
HK (1) HK1054508A1 (de)
HU (1) HUP0302371A3 (de)
IL (1) IL153245A0 (de)
IS (1) IS6653A (de)
MX (1) MXPA02012957A (de)
NO (1) NO20026177D0 (de)
NZ (1) NZ523188A (de)
PL (1) PL360484A1 (de)
RU (1) RU2271802C2 (de)
SE (1) SE0002354D0 (de)
SK (1) SK18072002A3 (de)
WO (1) WO2001097751A2 (de)
ZA (1) ZA200209908B (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007512347A (ja) 2003-11-26 2007-05-17 デューク・ユニバーシティー 緑内障を予防するかまたは治療する方法
KR100582347B1 (ko) * 2004-12-30 2006-05-22 한미약품 주식회사 3-하이드록시-3-메틸글루타릴 조효소 ａ 환원효소 억제제및 고혈압 치료제의 복합제제 및 그의 제조방법
KR100836321B1 (ko) 2006-10-31 2008-06-09 현대자동차주식회사 차량용 모니터 장치
CN103784425B (zh) * 2007-03-08 2016-08-17 日东电工株式会社 比索洛尔的经皮给药装置

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5175187A (en) * 1989-03-06 1992-12-29 Soorianarain Baligadoo Synergistic compositions for the treatment of coronary insufficiency and methods of use thereof
US5455269A (en) * 1989-03-06 1995-10-03 Baligadoo; Soorianarain Synergistic compositions of amiodarone and beta blockers
CA2106494A1 (en) * 1991-03-18 1992-09-19 James W. Young Composition and method containing optically pure (s) metoprolol
JP2648897B2 (ja) * 1991-07-01 1997-09-03 塩野義製薬株式会社 ピリミジン誘導体
NO177455C (no) * 1993-06-04 1995-09-20 Gerrit Elmenhorst Anordning ved apparat for fremstilling av brannslukkende skum
EP0904082A4 (de) * 1996-04-17 2001-09-26 Merck & Co Inc Kombinationstherapie zur verminderung der mit herz-kreislauferkrankungen einhergenden risiken
SE9602762D0 (sv) * 1996-07-12 1996-07-12 Astra Ab Carton and blank for forming the same
US5998458A (en) * 1997-06-25 1999-12-07 University Technology Corporation Method of treating heart failure
GT199800126A (es) * 1997-08-29 2000-01-29 Terapia de combinacion.
KR20020002367A (ko) * 1998-12-23 2002-01-09 윌리암스 로저 에이 심혈관 징후를 위한 조합물

Also Published As

Publication number Publication date
DE60124400T2 (de) 2007-10-31
WO2001097751A3 (en) 2002-03-28
JP2003535875A (ja) 2003-12-02
NO20026177L (no) 2002-12-20
HUP0302371A2 (hu) 2003-11-28
AU2001274766A1 (en) 2002-01-02
KR20030010750A (ko) 2003-02-05
HK1054508A1 (zh) 2003-12-05
MXPA02012957A (es) 2003-05-15
ES2274892T3 (es) 2007-06-01
AR028699A1 (es) 2003-05-21
SK18072002A3 (sk) 2003-08-05
IS6653A (is) 2002-12-11
EP1296716A2 (de) 2003-04-02
WO2001097751A2 (en) 2001-12-27
CN1437484A (zh) 2003-08-20
CA2411100A1 (en) 2001-12-27
NZ523188A (en) 2006-06-30
CZ20024181A3 (cs) 2003-04-16
HUP0302371A3 (en) 2007-03-28
BR0111790A (pt) 2003-05-20
US20030191177A1 (en) 2003-10-09
PL360484A1 (en) 2004-09-06
EP1296716B1 (de) 2006-11-08
ZA200209908B (en) 2004-03-05
US20060252814A1 (en) 2006-11-09
DE60124400D1 (de) 2006-12-21
ATE344675T1 (de) 2006-11-15
IL153245A0 (en) 2003-07-06
BG107373A (bg) 2003-09-30
SE0002354D0 (sv) 2000-06-22
RU2271802C2 (ru) 2006-03-20
NO20026177D0 (no) 2002-12-20

Similar Documents

Publication Publication Date Title
PT1572707E (pt) Novos derivados fluoroglicosideos aromaticos, farmacos contendo estes compostos e sua utilizacao
EE200000640A (et) Uus kasutamine
NO20023616L (no) Ny anvendelse
NL1016224A1 (nl) Foto-basevormend middel en foto-zuurvormend middel bevattende foto- etssamenstelling.
EP1508561A4 (de) BENZOATESÄURE-2-(a-HYDROXYPENTYL)ESTER UND DESSEN HERSTELLUNG UND VERWENDUNG
FIU20000164U0 (fi) Uusi farmaseuttinen formulaatio
DE60201461D1 (de) Arbeitsgerät, dessen Benutzer hinterher läuft
IT249353Y1 (it) Rete per uso chirurgico.
NO954834L (no) Lipoprotein-a-senkende middel, kolesterol-senkende middel, samt medikamenter omfattende disse
NO20030304D0 (no) Ny kombinasjon av serotoninagonist (5HT2) og antagonist (5HT6) som farmasöytisk formulering
BR0001396B1 (pt) aglomerante, processo para sua preparação, e, utilização do aglomerante.
NO20035121D0 (no) Ny anvendelse
IS2212B (is) 2-(3,5-Bis-trifluoromethyl-phenyl)-N-methyl-N-(6-morpholin-4-yl-4-o-tolyl-pyridin-3-yl)-isobutyrarramide
EE200200570A (et) Uus beeta-blokaatori ja kolesterooli alandava aine kombinatsioon
DK1149094T3 (da) 4-(aminoalkoxy)-benzofuraner som N-myristoyltransferase-inhibitorer
FI20011424L (fi) Tukiaseman resurssien hallinta ja tukiasema
EP1210084A4 (de) Pyridomorphinane, thienomorphinane und deren verwendung
EE9700065A (et) Uus keemiline ühend, selle valmistamine ja kasutamine ravimina
ID30464A (id) Pakaian luar sekali pakai untuk operasi pembedahan
EE200200703A (et) Beeta-blokaatorit ja vajadusel kolesterooli alandavat ainet sisaldav uus ravimvorm
NO20034524L (no) 5-leddete heterocykler, fremstilling og anvendelse derav som MAO inhibitorer og lipidperoksidasjonsinhibitorer, fremstilling derav oganvendelse derav sommedikamenter
FI20012140L (fi) Uudet kvaternääriset yhdisteet, niitä sisältävät koostumukset ja niiden käyttöjä
AR028122A1 (es) Nuevos compuestos aminotiolésteres, composiciones farmacéuticas y cosméticas que los contienen y utilizaciones
PT1341758E (pt) Coniosetina e seus derivados, processo para a sua preparacao e utilizacao dos mesmos
EE200300393A (et) Uus besoüülguanidiini sool